932OPhase III trial of lurbinectedin versus PLD or topotecan in platinum-resistant ovarian cancer patients: Results of CORAIL trial. (23rd October 2018) - Gaillard, S; Oaknin, A; Ray-Coquard, I L; Vergote, I B; Scambia, G; Colombo, N; Ghamande, S A; Soto-Matos, A; Fernandez, C M; Kahatt, C; Gomez, J; Nieto, A; et al.